HBIO Stock Analysis: Buy, Sell, or Hold?
HBIO - Harvard Bioscience Inc
$6.06
0.18 (3.15%)
▲
5d:
-0.41%
30d:
+12.13%
90d:
+14.9%
BUY
HIGH Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When HBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: HBIO shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: HBIO shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$5.06
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$3.14
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HBIO is currently trading at $6.05, which is considered fair relative to its 30-day fair value range of $5.49 to $6.35. From a valuation perspective, the stock is trading at a premium (Forward PE: 13.8) compared to its historical average (8.2). At these levels, the market is pricing in 18.7% annual earnings growth.
Technical Outlook: Technically, HBIO is in a strong uptrend. Immediate support is located at $5.66, while resistance sits at $6.69. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HBIO is in a strong uptrend. Immediate support is located at $5.66, while resistance sits at $6.69. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$5.49 -
$6.35
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.2%)
- NEUTRAL: Near Wall St target ($6.00)
- BULLISH: Expecting earnings turnaround to 18.7% growth with -4.7% revenue growth
Trading Range Analysis
30-Day Trading Range
$5.49 -
$6.35
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$5.66
Resistance Level
$6.69
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.76
Wall Street Target
$6.00
(-0.9%)
Revenue Growth (YoY)
-4.7%
Earnings Growth (YoY)
-80.3%
Profit Margin
-11.4%
Valuation Premium vs History
+18.7% premium
PE vs Historical
13.8 vs 8.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+18.7%
(market-implied from PE analysis)
1-Year Target
$7.19
(+19%)
2-Year Target
$8.53
(+41%)
3-Year Target
$10.13
(+67%)
3-Yr Target (if PE normalizes)
(PE: 14→8)
PE COMPRESSION
$6.03
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: June 23, 2026 5:20 AM ET
Data refreshes hourly during market hours. Next update: 6:20 AM
Data refreshes hourly during market hours. Next update: 6:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HBIO showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Stephen J Denelsky
BUY
10000 shares
2026-03-17
William Snider
BUY
8475 shares
2026-03-17
John D Duke
BUY
5000 shares
2026-03-16
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 58 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 55 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 55 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$359 | 64 BUY |
|
RMD
ResMed Inc |
BUY
19 analysts |
$262 | 62 BUY |
